| 8.58 0.33 (4%) | 04-15 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 11.24  |
1-year : | 12.47 |
| Resists | First : | 9.62 |
Second : | 10.68 |
| Pivot price | 9.39 |
|||
| Supports | First : | 7.92 |
Second : | 6.58 |
| MAs | MA(5) : | 8.81 |
MA(20) : | 9.46 |
| MA(100) : | 10.71  |
MA(250) : | 11.3 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 9 |
D(3) : | 9.6 |
| RSI | RSI(14): 37 |
|||
| 52-week | High : | 17 | Low : | 6.32 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ACCD ] has closed above bottom band by 15.6%. Bollinger Bands are 20.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.6 - 8.66 | 8.66 - 8.71 |
| Low: | 7.8 - 7.86 | 7.86 - 7.92 |
| Close: | 8.49 - 8.58 | 8.58 - 8.66 |
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Sun, 07 Apr 2024
Accolade, Inc. (NASDAQ:ACCD) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Fri, 05 Apr 2024
Accolade: Staying Bullish On Favorable Developments (NASDAQ:ACCD) - Seeking Alpha
Wed, 03 Apr 2024
Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results - GlobeNewswire
Mon, 01 Apr 2024
Recent uptick might appease Accolade, Inc. (NASDAQ:ACCD) institutional owners after losing 24% over the past year - Yahoo Finance
Wed, 20 Mar 2024
Accolade Wins 2024 Artificial Intelligence Excellence Award - PR Newswire
Sat, 17 Feb 2024
Why We're Not Concerned About Accolade, Inc.'s (NASDAQ:ACCD) Share Price - Simply Wall St
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 77 (M) |
| Shares Float | 70 (M) |
| Held by Insiders | 2.9 (%) |
| Held by Institutions | 88.1 (%) |
| Shares Short | 3,210 (K) |
| Shares Short P.Month | 2,410 (K) |
| EPS | -1.63 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.65 |
| Profit Margin | -31.6 % |
| Operating Margin | -32.1 % |
| Return on Assets (ttm) | -9.7 % |
| Return on Equity (ttm) | -26.7 % |
| Qtrly Rev. Growth | 9.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 5.01 |
| EBITDA (p.s.) | -1.15 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -25 (M) |
| Levered Free Cash Flow | 15 (M) |
| PE Ratio | -5.3 |
| PEG Ratio | 7.9 |
| Price to Book value | 1.51 |
| Price to Sales | 1.7 |
| Price to Cash Flow | -26.92 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|